These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22113390)

  • 21. Drugs indicated for use during pregnancy.
    Lalonde AB
    J Popul Ther Clin Pharmacol; 2011; 18(3):e513-5. PubMed ID: 22113337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
    Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Principles of Pharmacokinetics in the Pregnant Woman and Fetus.
    Ward RM; Varner MW
    Clin Perinatol; 2019 Jun; 46(2):383-398. PubMed ID: 31010566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
    Besunder JB; Reed MD; Blumer JL
    Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primer on clinical pharmacokinetics.
    Bauer LA
    Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of Orally Inhaled Drug Products.
    Hochhaus G; Horhota S; Hendeles L; Suarez S; Rebello J
    AAPS J; 2015 May; 17(3):769-75. PubMed ID: 25762449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.
    Anderson GD
    Clin Pharmacokinet; 2005; 44(10):989-1008. PubMed ID: 16176115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bio-International 92, conference on bioavailability, bioequivalence, and pharmacokinetic studies.
    Blume HH; Midha KK
    J Pharm Sci; 1993 Nov; 82(11):1186-9. PubMed ID: 7904641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics in the newborn.
    Alcorn J; McNamara PJ
    Adv Drug Deliv Rev; 2003 Apr; 55(5):667-86. PubMed ID: 12706549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
    Dallmann A; Ince I; Coboeken K; Eissing T; Hempel G
    Clin Pharmacokinet; 2018 Jun; 57(6):749-768. PubMed ID: 28924743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioequivalence studies: single vs multiple dose.
    Steinijans VW; Sauter R; Jonkman JH; Schulz HU; Stricker H; Blume H
    Int J Clin Pharmacol Ther Toxicol; 1992; 30 Suppl 1():S31-6. PubMed ID: 1601529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic-pharmacodynamic relationship.
    Baggot JD
    Ann Rech Vet; 1990; 21 Suppl 1():29S-40S. PubMed ID: 2080844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in drug disposition during pregnancy: implications for drug therapy.
    Hodge LS; Tracy TS
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):557-71. PubMed ID: 17696806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship Between Adherence Rate Threshold and Drug 'Forgiveness'.
    Morrison A; Stauffer ME; Kaufman AS
    Clin Pharmacokinet; 2017 Dec; 56(12):1435-1440. PubMed ID: 28470545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of physicochemical and pharmacokinetic parameters in lead optimization: a physiological pharmacokinetic model based approach.
    Benjamin B; Barman TK; Chaira T; Paliwal JK
    Curr Drug Discov Technol; 2010 Sep; 7(3):143-53. PubMed ID: 20843296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obstetric therapeutics-how pharmacogenetics may inform drug therapy for pregnant women in the future.
    Haas DM
    Obstet Gynecol Surv; 2013 Sep; 68(9):650-4. PubMed ID: 25102121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Impact of ECMO on drugs pharmacokinetics].
    Hasni N; Lemaitre F; Fernandez C; Combes A; Farinotti R
    Therapie; 2011; 66(5):405-12. PubMed ID: 22031684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.
    Poulin P
    J Pharm Sci; 2015 Jul; 104(7):2359-68. PubMed ID: 25943586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update.
    Alsmadi MM; Idkaidek N
    Curr Drug Metab; 2018; 19(12):972-978. PubMed ID: 29962340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of drugs in pregnancy.
    Knoppert D
    J Popul Ther Clin Pharmacol; 2011; 18(3):e506-12. PubMed ID: 22113261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.